Top Markets
Coin of the day
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rang in aandelen #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Aandeelprijs
$2.22
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$117.70M
Verandering (1 dag)
2.69%
Verandering (1 jaar)
17.26%
Land
SE
Handel SynAct Pharma AB (SYNACT)

Categorie

Koersgeschiedenis voor SynAct Pharma AB (SYNACT)
Hoogste slotkoers: $2.19 op 2026-08-01

Laagste slotkoers: $0.56 op 2016-07-01
Koersgeschiedenis van SynAct Pharma AB van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -7.35%
2025 144.78%
2024 17.64%
2023 -89.62%
2022 -48.77%
2021 236.22%
2020 376.82%
2019 16.49%
2018 -27.27%
2017 82.38%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH